99896-85-2

  • Product Name:arg-gly-asp
  • Molecular Formula:C12H22N6O6
  • Molecular Weight:346.343
Inquiry

Product Details

pd_meltingpoint:153-155℃ (ethyl ether )

Purity:99%

Buy High Grade lowest price of arg-gly-asp 99896-85-2 new batch stock

  • Molecular Formula:C12H22N6O6
  • Molecular Weight:346.343
  • Vapor Pressure:0mmHg at 25°C 
  • Melting Point:153-155℃ (ethyl ether ) 
  • Refractive Index:1.671 
  • Boiling Point:597.205°C at 760 mmHg 
  • PKA:2.85±0.10(Predicted) 
  • Flash Point:314.979°C 
  • PSA:220.72000 
  • Density:1.61 g/cm3 
  • LogP:-0.58970 

ARG-GLY-ASP(Cas 99896-85-2) Usage

Chemical Properties

White to off-white powder

Uses

Arg-Gly-Asp has been used:to saturate the cell surface Arg-Gly-Asp (RGD) receptors and inhibit marrow stromal cell (MSC) attachment to peptide modified hydrogelin adhesion assayin inhibition assay to confirm the β1-integrin-dependency of cell adhesionin textile fabrication and RGD textile functionalizationto engineer a population of human dermal fibroblasts with impaired migrationto modify glass substrate and evaluate the behavior of human bone marrow mesenchymal stem cells (hBM-MSCs)in the cell culture of human mammary epithelial cells

General Description

Arg-Gly-Asp (RGD) is an integrin binding site, which belongs to the class of adhesive proteins. It functions as a brain tumor targeting ligand.

Biological Activity

synthetic peptides containing the arginine-glycine-aspartate (rgd) were extensively used as inhibitors of integrin-ligand interactions in studies of cell adhesion, migration, growth and differentiation, since the rgd motif is an integrin-recognition motif found in many ligands.

Biochem/physiol Actions

Primary sequence involved with the binding of proteins to cell surfaces

in vitro

rgd peptide can induce apoptosis in the absence of signals and integrin-mediated cell clustering. previous study demonstrates that rgd peptides promote apoptosis through activation of conformation changes enhancing pro-caspase-3 activation and autoprocessing [1].

in vivo

anima study suggested that the rgd-4c-fitc-peptide bound to both endothelial and tumor cells in vivo and that peptide targeting should allow the delivery of therapeutic drugs to both endothelial and tumor cells [2].

references

[1] nature. 1999 feb 11;397(6719):534-9.rgd peptides induce apoptosis by direct caspase-3 activation. buckley cd1, pilling d, henriquez nv, parsonage g, threlfall k, scheel-toellner d, simmons dl, akbar an, lord jm, salmon m. [2] cancer res. 2002 sep 15;62(18):5139-43. arginine-glycine-aspartic acid (rgd)-peptide binds to both tumor and tumor-endothelial cells in vivo. zitzmann s1, ehemann v, schwab m.

InChI:InChI=1/C12H22N6O6/c13-4-6(19)12(17,10(23)24)7(9(21)22)8(20)5(14)2-1-3-18-11(15)16/h5,7H,1-4,13-14,17H2,(H,21,22)(H,23,24)(H4,15,16,18)

99896-85-2 Relevant articles

Synthesis of Modified RGD-Based Peptides and Their in vitro Activity

Hamdan, Fatima,Bigdeli, Zahra,Asghari, S. Mohsen,Sadremomtaz, Afsaneh,Balalaie, Saeed

supporting information, p. 282 - 288 (2019/01/14)

Arg-Gly-Asp (RGD) peptides represent the...

Arg-Gly-Asp (RGD) Sequence Containing Cyclic Peptide and Its Active Targeting Liposomes

-

, (2010/05/13)

The present invention relates to the fie...

Preparation and biological activities of a bivalent poly(ethylene glycol) hybrid containing an active site and its synergistic site of fibronectin.

Susuki, Yuichi,Hojo, Keiko,Okazaki, Ikuko,Kamata, Haruhiko,Sasaki, Masahiko,Maeda, Mitsuko,Nomizu, Motoyoshi,Yamamoto, Yoko,Nakagawa, Shinsaku,Mayumi, Tadanori,Kawasaki, Koichi

, p. 1229 - 1232 (2007/10/03)

A bivalent poly(ethylene glycol) or PEG ...

Synthesis and antiviral activity of VP1 fragments of the aphthous fever virus

Rybakov,Belyaeva,Pronin,Pavlov,Lugovskoi,Petrov

, p. 641 - 645 (2007/10/03)

-

99896-85-2 Process route

glycyl-L-aspartic acid
4685-12-5

glycyl-L-aspartic acid

N<sup>α</sup>,N<sup>G</sup>,N<sup>G'</sup>-tri-Boc-L-arginine N-hydroxysuccinimide ester
108787-79-7

Nα,NG,NG'-tri-Boc-L-arginine N-hydroxysuccinimide ester

Arg-Gly-Asp
99896-85-2,119865-10-0

Arg-Gly-Asp

Conditions
Conditions Yield
glycyl-L-aspartic acid; Nα,NG,NG'-tri-Boc-L-arginine N-hydroxysuccinimide ester; With 4-methyl-morpholine; In N,N-dimethyl-formamide; at 20 ℃; for 24h;
With trifluoroacetic acid; In chloroform;
54%
p-cresol
106-44-5

p-cresol

thiophenol
108-98-5

thiophenol

Arg-Gly-Asp
99896-85-2,119865-10-0

Arg-Gly-Asp

Conditions
Conditions Yield
In hydrogen fluoride;

99896-85-2 Upstream products

  • 4685-12-5
    4685-12-5

    glycyl-L-aspartic acid

  • 108787-79-7
    108787-79-7

    Nα,NG,NG'-tri-Boc-L-arginine N-hydroxysuccinimide ester

  • 29022-11-5
    29022-11-5

    N-(fluoren-9-ylmethoxycarbonyl)glycine

  • 71989-14-5
    71989-14-5

    Fmoc-(tBu)Asp-OH

99896-85-2 Downstream products

  • 2174-58-5
    2174-58-5

    L-malic acid

  • 74-79-3
    74-79-3

    L-arginine

  • 56-40-6
    56-40-6

    glycine

Relevant Products